title: Primary care diagnostic technology update: point-of-care testing for glycosylated haemoglobin.
abstract: In the monitoring of patients with type 1 and type 2 diabetes, what advantages does point-of-care HbA(1c) testing provide over current practice?
authors.affiliation: Primary Care Diagnostic Horizon Scanning, Centre for Monitoring and Diagnosis Oxford, Department of Primary Health Care, University of Oxford, Oxford, UK. horizonscanning@dphpc.ox.ac.uk
authors.forename: Annette
authors.initials: A
authors.lastname: Plüddemann
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Price
authors.forename: Matthew
authors.initials: M
authors.lastname: Thompson
authors.forename: Jane
authors.initials: J
authors.lastname: Wolstenholme
authors.forename: Carl
authors.initials: C
authors.lastname: Heneghan
mesh_terms: D000328:Adult; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis*; D006442:Glycated Hemoglobin / Q000032:analysis* / Q000378:metabolism; D006801:Humans; D019095:Point-of-Care Systems; D016032:Randomized Controlled Trials as Topic; D055815:Young Adult
chemical_list: D006442:Glycated Hemoglobin